Buyside appetite in OTC derivatives remains undiminished

Sponsored

Like most major regulatory changes, the introduction of new margin, collateral and capital requirements for non-cleared OTC derivatives has been subject to delay as regulators finalise the details and dealers are struggling with their implementation. With its global start date already having been delayed from Q3 2015 to 2016, Europe is now pushing back further, most likely to Q2 1017.